Lonza to Launch XPressEV™ Bioactive Functional for the Appearance of Firmer, Fitter Skin at in-cosmetics Asia


  • Lonza’s XPressEV™ bioactive functional helps reduce the visible effects of chronological aging, leading to the appearance of firmer and “fitter” skin.
  • XPressEV™ is an “evolution in personal care for skin surface architecture.”
South Plainfield, NJ (USA) - 29 October 2018
At in-cosmetics Asia 2018 Lonza will launch XPressEV™ bioactive functional, which helps reduce the visible effects of chronological aging, leading to the appearance of firmer and “fitter” skin. In-cosmetics Asia 2018 takes place 30 October through 1 November in Bangkok (TH). Lonza will be at Stand N10.

Like workouts help keep your muscles fit, XPressEV™ bioactive is designed to help keep your skin looking fitter, giving you a healthier, younger appearance,” said Jennifer Clancy, Senior Director of Global Marketing, Lonza Consumer Product Ingredients. “XPressEV™ bioactive is a workout for your skin and works as hard as you do in your daily workout routine.

Lonza’s premium skin-care ingredient, XPressEV™ bioactive functional is suitable for formulations designated for areas where consumers require firmer, fitter skin, primarily the face but also the neck and hands. It is targeted for consumers of both genders and of all ages.

XPressEV™ bioactive is especially relevant to Asian consumers,” said Vanessa Arruda, PhD, Global Market Development Manager, Bioactives. “While wrinkling starts later in life (at about 40) for Asian consumers than for the rest of us, it happens faster, so they should begin early to help in reducing the wrinkling process.

XPressEV™ bioactive is an “evolution for personal care in skin surface architecture” because it works within the skin layers targeting the dermis and the dermal-epidermal junction (DEJ).

Proven Results
Independent ex vivo efficacy tests showed that XPressEV™ bioactive helps to strengthen the DEJ by enhancing expression of Collagen VII and Laminin 5. The testing showed increases of 103 percent and 123 percent respectively. In addition, XPressEV™ bioactive helps improve the dermal architecture by increasing the expression not only of Collagen II -- by 80 percent -- and elastin -- by 31 percent, but also decorin, which saw a 138 percent increase. A protein linked to collagen, decor makes collagen stronger.

In vivo evaluations showed that the facial contour area at the lower cheek and jaw appeared more toned versus the control emulsion,” Arruda added. “In addition, the skin texture appeared smoother and wrinkles were less visible.”

XPressEV™ bioactive functional is created using cutting edge Supercritical CO2 extraction, a more environmentally friendly process than traditional extraction techniques, to obtain extract of Morus Nigra from mulberry leaves. Other ingredients are pearl extract, which has been used in traditional Chinese remedies and cosmetics for hundreds of years; linseed oil and canola oil.

ScreenLight™ Block
Lonza also will feature its award-winning ScreenLight™ Block bioactive functional, which helps protect skin from the visible effects of blue light and environmental stressors such as UV light and pollution. Lonza recently showcased ScreenLight™ Block at in-cosmetics Latin America 2018 and received the ITEHPEC* Innovation Award Finalist Recognition for the bioactive functional.

ScreenLight™ Block provides a powerful defensive shield against the visible skin-aging effects of blue light. In addition, it helps protect skin against the effects of UV stress and pollution.

Asian consumers spend more time looking at their digital devices than any other region in the world,” Arruda said. “So ScreenLight™ Block is particularly important for Asian consumers who understand that their digital screen time plus the region’s environmental stress factors may negatively affect their skin.

ScreenLight™ Block is suitable for such skin-care formulations as facial cream and after-shave lotion, for make-up and for gentle cosmetic formulations.

Key Attributes
ScreenLight™ Block helps reduce the appearance of dark spots, resulting in skin that appears more evenly toned (based on in vivo clinical data). It helps reduce the appearance of fine lines and wrinkles (based on subjects’ perceptions of themselves), and it helps prevent increased melanin production from exposure to visible light and pollution (based on ex vivo data).

Lonza produces the ScreenLight™ Block by using Supercritical CO2 extraction to obtain the Physalis alkekengi extract from the subtropical Chinese lantern fruit.

*ITEHPEC (Innovation and Technology in Cosmetics, Toiletries and Fragrances) is the Innovation and Technology chapter of the Brazilian Association of the Personal Hygiene, Perfumery and Cosmetics Industry.

About Lonza Consumer Product Ingredients – Personal Care
Part of Lonza’s Consumer Product Ingredients business unit, the Personal Care business is a world’s leading supplier of active antidandruff agents, with its Zinc Omadine® product considered the gold standard in the antidandruff shampoo market. Lonza Personal Care also supplies a wide array of other hair- and skin-care products, including biotechnology-derived active ingredients, preservatives for use in certified natural and organic products, specialty esters, functional ingredients and more. More information about these products can be found at www.lonza.com/personalcare.

About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.

Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.

Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fastmoving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.

Founded in 1897 in the Swiss Alps, Lonza today is a wellrespected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.

« back